Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?
about
Rituximab Effectiveness and Safety for Treating Primary Sjögren's Syndrome (pSS): Systematic Review and Meta-AnalysisSalivary Secretory Disorders, Inducing Drugs, and Clinical ManagementSystems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model.Possible Mechanisms of Lymphoma Development in Sjögren's Syndrome.The immune factors involved in the pathogenesis, diagnosis, and treatment of Sjogren's syndromeEfficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.Biologics in oral medicine: Sjogren syndrome.The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.Functional salivary gland regeneration as the next generation of organ replacement regenerative therapy.EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) is sensitive to show efficacy of rituximab treatment in a randomised controlled trial.Chronic Autoimmune Epithelitis in Sjögren's Syndrome and Primary Biliary Cholangitis: A Comprehensive Review.Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
P2860
Q26753072-B05A9BF7-F6C7-428B-B5F9-DE976B53A55DQ26777907-003E8AB3-B20F-41BE-A0A9-05D1ED350321Q36907609-AF60D4F8-BA98-4475-8B45-A000A6B1C231Q36998409-6D14A4A4-C80D-49B4-B361-0EDEF794075FQ37044113-02743228-B387-4836-B2C2-5E38F84CB446Q37691074-AD34B8A9-AC81-4AD3-B84D-C62FDA782353Q38002156-29529CFC-A389-4B85-B371-69808B7F0B96Q38355697-8EFA6680-D8BA-487D-9363-BDFD7EAE5A7BQ38547269-7C179659-226D-40A9-8C67-1AA2F6A2316CQ43695088-4398FD23-0044-499F-B6F6-65E0B8754D24Q47146987-ABD13106-BC6D-4FEC-B815-819CD1BE76DFQ54310740-7F11ADEF-607A-4EF2-9935-9CEAF5E00D00
P2860
Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment of primary Sjögren's ...... oach or just a starting point?
@en
Treatment of primary Sjögren's syndrome with anti-CD20 therapy
@nl
type
label
Treatment of primary Sjögren's ...... oach or just a starting point?
@en
Treatment of primary Sjögren's syndrome with anti-CD20 therapy
@nl
prefLabel
Treatment of primary Sjögren's ...... oach or just a starting point?
@en
Treatment of primary Sjögren's syndrome with anti-CD20 therapy
@nl
P2093
P2860
P1476
Treatment of primary Sjögren's ...... oach or just a starting point?
@en
P2093
Arjan Vissink
Frans G M Kroese
Hendrika Bootsma
Petra M Meiners
P2860
P304
P356
10.1517/14712598.2011.605352
P407
P577
2011-08-07T00:00:00Z